Ethnic differences in the prevalence of cryptogenic cirrhosis
- PMID: 15046220
- DOI: 10.1111/j.1572-0241.2004.04059.x
Ethnic differences in the prevalence of cryptogenic cirrhosis
Abstract
Objectives: Nonalcoholic steatohepatitis (NASH) associated with obesity and type 2 diabetes mellitus (DM) is postulated to be the cause of most cases of cryptogenic cirrhosis (CC). While ethnic differences in the prevalence of obesity and DM in the United States are well documented, there is little information regarding prevalence of CC or NASH among different U.S. ethnic groups. This study was performed to assess the demographic characteristics of patients with CC at a U.S. county hospital with a racially and ethnically diverse patient population.
Methods: Medical records and pathology databases were reviewed to identify patients at Parkland Memorial Hospital, Dallas County, Texas from 1990 to 2001 with CC or cirrhosis attributed to NASH.
Results: Forty-one patients (12 men, 29 women) were found to meet these criteria. Of these, 68% were obese (BMI > or = 30) and/or had type 2 DM and 74% of liver biopsies revealed one or more features of NASH. Of patients with CC 68% were Hispanic while only 7% were African American, despite the fact that Hispanics comprised < 26% and African Americans > 40% of adult medicine patients. Prevalence of CC among Hispanic and African American patients was 3.1-fold higher and 3.9-fold lower, respectively, than among European American patients despite similar prevalence of DM among Hispanics and African Americans.
Conclusion: These findings support the hypothesis that NASH associated with obesity and DM is responsible for the majority of cases of CC among Hispanics and European Americans. However, the current findings also indicate that this form of cirrhosis is unexpectedly rare among African Americans.
Similar articles
-
Is cryptogenic cirrhosis different from NASH cirrhosis?J Hepatol. 2018 Mar;68(3):519-525. doi: 10.1016/j.jhep.2017.11.018. Epub 2017 Nov 21. J Hepatol. 2018. PMID: 29162389
-
Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis.World J Gastroenterol. 2008 Aug 14;14(30):4771-5. doi: 10.3748/wjg.14.4771. World J Gastroenterol. 2008. PMID: 18720537 Free PMC article.
-
Is NASH underdiagnosed among African Americans?Am J Gastroenterol. 2002 Jun;97(6):1496-500. doi: 10.1111/j.1572-0241.2002.05795.x. Am J Gastroenterol. 2002. PMID: 12094872
-
[Non-alcoholic fatty liver: 10 years' experience at the Insituto Nacional de la Nutrición Salvador Zubirán].Rev Invest Clin. 1994 Mar-Apr;46(2):85-92. Rev Invest Clin. 1994. PMID: 8052745 Review. Spanish.
-
Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments.Z Gastroenterol. 2019 Apr;57(4):508-517. doi: 10.1055/a-0784-8827. Epub 2019 Apr 9. Z Gastroenterol. 2019. PMID: 30965381 Review. English.
Cited by
-
Emerging risk factors for nonalcoholic fatty liver disease associated hepatocellular carcinoma.Hepatoma Res. 2020;6:35. doi: 10.20517/2394-5079.2020.16. Epub 2020 Jun 18. Hepatoma Res. 2020. PMID: 32685690 Free PMC article.
-
Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and _targets of Therapies?Int J Mol Sci. 2021 May 20;22(10):5375. doi: 10.3390/ijms22105375. Int J Mol Sci. 2021. PMID: 34065331 Free PMC article. Review.
-
An Endocrine Perspective of Nonalcoholic Fatty Liver Disease (NAFLD).Ther Adv Endocrinol Metab. 2011 Oct;2(5):211-25. doi: 10.1177/2042018811419157. Ther Adv Endocrinol Metab. 2011. PMID: 23148186 Free PMC article.
-
RAGE is a Potential Cause of Onset and Progression of Nonalcoholic Fatty Liver Disease.Int J Endocrinol. 2019 Sep 18;2019:2151302. doi: 10.1155/2019/2151302. eCollection 2019. Int J Endocrinol. 2019. PMID: 31641351 Free PMC article. Review.
-
Non-Alcoholic Fatty Liver Disease: Current Perspectives and Future Direction in Disease pathogenesis, Treatment and Diagnosis.Med Chem (Los Angeles). 2012 Aug 3;2:e104. doi: 10.4172/2161-0444.1000e104. Med Chem (Los Angeles). 2012. PMID: 24660114 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases